Close
  Indian J Med Microbiol
 

Figure 6. Valproic acid (VPA) treatment inhibits tumor growth in vivo. (a) SAS xenograft-bearing NOD/SCID mice were treated daily with VPA (400 mg/kg/ day) or vehicle, and the tumors were examined on day 13. (b) Mean tumor weights were compared between VPA-treated and vehicle control-treated groups (n = 7; ***P < 0.001) (c) Tumor volumes of SAS xenografts in the mice treated with VPA or vehicle were measured at indicated times (n = 7). (d) Body weights in VPA-treated (400 mg/kg/day) and vehicle control-treated mice were monitored daily

Figure 6. Valproic acid (VPA) treatment inhibits tumor growth <i>in vivo</i>. (a) SAS xenograft-bearing NOD/SCID mice were treated daily with VPA (400 mg/kg/ day) or vehicle, and the tumors were examined on day 13. (b) Mean tumor weights were compared between VPA-treated and vehicle control-treated groups (<i>n</i> = 7; ***<i>P</i> < 0.001) (c) Tumor volumes of SAS xenografts in the mice treated with VPA or vehicle were measured at indicated times (<i>n</i> = 7). (d) Body weights in VPA-treated (400 mg/kg/day) and vehicle control-treated mice were monitored daily